A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).

Taipei Veterans General Hospital ( Site 1703), Taipei

Macquarie University-MQ Health Clinical Trials Unit ( Site 1502), Macquarie University

Westmead Hospital ( Site 1501), Westmead

Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si, Brisbane

Fiona Stanley Hospital-Medical Oncology ( Site 1503), Murdoch

Memorial Sloan Kettering Cancer Center ( Site 0100), New York

Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0401), Berlin

Abramson Cancer Center ( Site 0107), Philadelphia

Fox Chase Cancer Center ( Site 0111), Philadelphia

Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 0500), Milan

Asklepios Altona-Department of Urology ( Site 0410), Hamburg

CHU Besançon ( Site 0302), Besançon

Duke Cancer Institute ( Site 0106), Durham

Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 0801), Madrid

Institut Claudius Regaud ( Site 0303), Toulouse

Ege Universitesi Hastanesi-Medical Oncology ( Site 0903), Izmir

China Medical University Hospital-Department of Urology ( Site 1702), Taichung

Taichung Veterans General Hospital ( Site 1704), Taichung

HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 0802), Seville

Azienda Ospedaliero Universitaria di Parma ( Site 0503), Parma

Azienda Ospedaliera Universitaria Careggi-SOD ONCOLOGIA MEDICA ( Site 0504), Florence

CENTRE LEON BERARD ( Site 0305), Lyon Cedex08

Klinikum Stuttgart - Katharinenhospital ( Site 0400), Stuttgart

Hôpital Européen Georges Pompidou ( Site 0300), Paris

UT Southwestern Medical Center ( Site 0110), Dallas

klinikum rechts der isar der technischen universität münchen-Urologische Klinik und Poliklinik ( Sit, Munich

Chang Gung Memorial Hospital at Kaohsiung-Oncology and Hematology ( Site 1701), Kaohsiung Niao Sung Dist

UCLA Hematology/Oncology - Westwood (Building 200 Suite 140)-Department of Urology/Institute of Uro, Los Angeles

City of Hope Comprehensive Cancer Center-Medical Oncology ( Site 0104), Duarte

UCSF Medical Center at Mission Bay ( Site 0108), San Francisco

Gustave Roussy ( Site 0304), Villejuif

ONCOCENTRO APYS-ACEREY ( Site 1200), Viña del Mar

FALP-UIDO ( Site 1202), Santiago

Pontificia Universidad Catolica de Chile-Centro del Cáncer ( Site 1205), Santiago

Bradfordhill-Clinical Area ( Site 1201), Santiago

Yale-New Haven Hospital-Yale Cancer Center ( Site 0102), New Haven

Beth Israel Deaconess Medical Center-Cancer Clinical Trials Office ( Site 0109), Boston

Dana-Farber Cancer Institute-GU ( Site 0101), Boston

Hospital Británico de Buenos Aires-Oncology ( Site 1106), Ciudad Autónoma de Buenos Aires

Instituto Alexander Fleming-Alexander Fleming ( Site 1101), Buenos Aires

Asociación de Beneficencia Hospital Sirio Libanés ( Site 1110), Buenos Aires

Centro Privado de RMI Rio Cuarto ( Site 1104), Río Cuarto

Fundacion Estudios Clinicos ( Site 1111), Rosario

BC Cancer Vancouver ( Site 0005), Vancouver

CHU de Quebec - Université Laval - Hotel Dieu de Quebec ( Site 0008), Québec

Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Urologie ( Site 0405), Dresden

Universitätsklinikum Jena ( Site 0402), Jena

Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 0501), Rome

Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 0701), Bydgoszcz

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworów Układu Moczowego ( S, Warsaw

Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 0702), Koszalin

Seoul National University Hospital ( Site 1600), Seoul

Severance Hospital, Yonsei University Health System ( Site 1603), Seoul

Asan Medical Center ( Site 1602), Seoul

Samsung Medical Center ( Site 1601), Seoul

Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 0800), Barcelona

Hacettepe Universite Hastaneleri-oncology hospital ( Site 0901), Ankara

Ankara Universitesi Tip Fakultesi Hastanesi-Oncology ( Site 0902), Ankara

Addenbrooke's Hospital ( Site 1004), Cambridge

Gartnavel General Hospital-Clinical Trials Unit ( Site 1002), Glasgow

St Bartholomew's Hospital ( Site 1000), London

Western General Hospital ( Site 1003), Edinburgh

The Christie NHS Foundation Trust ( Site 1001), Manchester